SOPH
SOPHiA GENETICS S.A.- Healthcare
- Medical - Healthcare Information Services
- $660M market cap
Forecast run · Sep 14, 2026Upside rank 735 of 3,136
Model Signal
ForecastQ Daily Probabilities
50.3%
34.9%
25.5%
Analyst Consensus
Recommendation2.13/5 Buy
Last price$7.87
Price target$11.50
Implied move+46.1%
Analysts8
ForecastQ Portfolios
SOPH is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.